146436-31-9 Usage
Molecular structure
A beta-carboline derivative with an isobutyl group attached to the first position, a carboxylic acid group attached to the third position, and a tetrahydro ring structure.
Psychoactive properties
Potential psychoactive properties that may affect the central nervous system.
Neurotransmitter modulation
Known to modulate neurotransmitter systems in the brain.
Drug target
Contains a carboxylic acid group, making it a potential drug target for pharmaceutical research.
Potential applications
Could potentially be used in the development of drugs for neurological disorders or psychiatric conditions, as well as in the fields of behavioral science and neuropsychopharmacology.
Further research needed
More research is needed to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 146436-31-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,4,3 and 6 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 146436-31:
(8*1)+(7*4)+(6*6)+(5*4)+(4*3)+(3*6)+(2*3)+(1*1)=129
129 % 10 = 9
So 146436-31-9 is a valid CAS Registry Number.
146436-31-9Relevant academic research and scientific papers
Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
-
, (2008/06/13)
PCT No. PCT/EP97/01582 Sec. 371 Date Nov. 12, 1998 Sec. 102(e) Date Nov. 12, 1998 PCT Filed Mar. 27, 1997 PCT Pub. No. WO97/37658 PCT Pub. Date Oct. 16, 1997The present invention concerns the use of beta-carboline derivatives of formula I bearing at least a free or esterified carboxylic group on the piperidine ring, for the preparation of pharmaceutical compositions having antimetastatic properties.
